Medpace Holdings, Inc. Earnings Per Share (Basic)
Medpace Holdings, Inc. (MEDP) reported Earnings Per Share (Basic) of $4.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-23
- Medpace Holdings, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $4.31, a 36.39% increase year-over-year.
- Medpace Holdings, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $4.35, a 15.38% increase year-over-year.
- Medpace Holdings, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $4.78, a 26.36% increase year-over-year.
- Medpace Holdings, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $3.95, a 27.01% increase year-over-year.
- Medpace Holdings, Inc. earnings per share, basic for fiscal 2025 was $15.64, a 19.75% increase from fiscal 2024.
- Medpace Holdings, Inc. earnings per share, basic for fiscal 2024 was $13.06, a 41.96% increase from fiscal 2023.
- Medpace Holdings, Inc. earnings per share, basic for fiscal 2023 was $9.20, a 21.53% increase from fiscal 2022.
- Medpace Holdings, Inc. earnings per share, basic for fiscal 2022 was $7.57, a 49.60% increase from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.31 10-Q · filed 2026-07-23 | $8.66 10-Q · filed 2026-07-23 | ||
| 2026-03-31 | $4.35 10-Q · filed 2026-04-23 | |||
| 2025-12-31 | $4.78 derived: net income ÷ weighted average shares · filed 2026-02-10 | $8.73 derived: net income ÷ weighted average shares · filed 2026-02-10 | $11.87 derived: net income ÷ weighted average shares · filed 2026-07-23 | $15.64 10-K · filed 2026-02-10 |
| 2025-09-30 | $3.95 10-Q · filed 2025-10-23 | $7.10 derived: net income ÷ weighted average shares · filed 2026-07-23 | $10.88 10-Q · filed 2025-10-23 | $14.67 derived: net income ÷ weighted average shares · filed 2026-07-23 |
| 2025-06-30 | $3.16 10-Q · filed 2026-07-23 | $6.95 10-Q · filed 2026-07-23 | $10.74 derived: net income ÷ weighted average shares · filed 2026-07-23 | $13.83 derived: net income ÷ weighted average shares · filed 2026-07-23 |
| 2025-03-31 | $3.77 10-Q · filed 2026-04-23 | $7.55 derived: net income ÷ weighted average shares · filed 2026-04-23 | $10.65 derived: net income ÷ weighted average shares · filed 2026-04-23 | $13.50 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2024-12-31 | $3.78 derived: net income ÷ weighted average shares · filed 2026-02-10 | $6.89 derived: net income ÷ weighted average shares · filed 2026-02-10 | $9.74 derived: net income ÷ weighted average shares · filed 2026-02-10 | $13.06 10-K · filed 2026-02-10 |
| 2024-09-30 | $3.11 10-Q · filed 2025-10-23 | $5.96 derived: net income ÷ weighted average shares · filed 2025-10-23 | $9.28 10-Q · filed 2025-10-23 | $11.83 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2024-06-30 | $2.85 10-Q · filed 2025-07-22 | $6.17 10-Q · filed 2025-07-22 | $8.72 derived: net income ÷ weighted average shares · filed 2026-02-10 | $11.03 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2024-03-31 | $3.32 10-Q · filed 2025-04-22 | $5.87 derived: net income ÷ weighted average shares · filed 2026-02-10 | $8.18 derived: net income ÷ weighted average shares · filed 2026-02-10 | $10.18 derived: net income ÷ weighted average shares · filed 2026-02-10 |
| 2023-12-31 | $2.55 derived: net income ÷ weighted average shares · filed 2026-02-10 | $4.85 derived: net income ÷ weighted average shares · filed 2026-02-10 | $6.85 derived: net income ÷ weighted average shares · filed 2026-02-10 | $9.20 10-K · filed 2026-02-10 |
| 2023-09-30 | $2.30 10-Q · filed 2024-10-22 | $4.30 derived: net income ÷ weighted average shares · filed 2024-10-22 | $6.65 10-Q · filed 2024-10-22 | $8.85 derived: net income ÷ weighted average shares · filed 2025-02-11 |
| 2023-06-30 | $2.00 10-Q · filed 2024-07-23 | $4.35 10-Q · filed 2024-07-23 | $6.55 derived: net income ÷ weighted average shares · filed 2025-02-11 | $8.68 derived: net income ÷ weighted average shares · filed 2025-02-11 |
| 2023-03-31 | $2.35 10-Q · filed 2024-04-23 | $4.55 derived: net income ÷ weighted average shares · filed 2025-02-11 | $6.68 derived: net income ÷ weighted average shares · filed 2025-02-11 | $8.17 derived: net income ÷ weighted average shares · filed 2025-02-11 |
| 2022-12-31 | $2.20 derived: net income ÷ weighted average shares · filed 2025-02-11 | $4.33 derived: net income ÷ weighted average shares · filed 2025-02-11 | $5.83 derived: net income ÷ weighted average shares · filed 2025-02-11 | $7.57 10-K · filed 2025-02-11 |
| 2022-09-30 | $2.13 10-Q · filed 2023-10-24 | $3.63 derived: net income ÷ weighted average shares · filed 2023-10-24 | $5.39 10-Q · filed 2023-10-24 | $6.74 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2022-06-30 | $1.52 10-Q · filed 2023-07-25 | $3.28 10-Q · filed 2023-07-25 | $4.66 derived: net income ÷ weighted average shares · filed 2024-02-13 | $6.01 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2022-03-31 | $1.75 10-Q · filed 2023-04-25 | $3.14 derived: net income ÷ weighted average shares · filed 2024-02-13 | $4.49 derived: net income ÷ weighted average shares · filed 2024-02-13 | $5.60 derived: net income ÷ weighted average shares · filed 2024-02-13 |
| 2021-12-31 | $1.39 derived: net income ÷ weighted average shares · filed 2024-02-13 | $2.74 derived: net income ÷ weighted average shares · filed 2024-02-13 | $3.85 derived: net income ÷ weighted average shares · filed 2024-02-13 | $5.06 10-K · filed 2024-02-13 |
| 2021-09-30 | $1.35 10-Q · filed 2022-10-25 | $2.46 derived: net income ÷ weighted average shares · filed 2022-10-25 | $3.67 10-Q · filed 2022-10-25 | $5.09 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-06-30 | $1.11 10-Q · filed 2022-07-26 | $2.32 10-Q · filed 2022-07-26 | $3.74 derived: net income ÷ weighted average shares · filed 2023-02-14 | $4.90 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-03-31 | $1.21 10-Q · filed 2022-04-26 | $2.63 derived: net income ÷ weighted average shares · filed 2023-02-14 | $3.79 derived: net income ÷ weighted average shares · filed 2023-02-14 | $4.48 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2020-12-31 | $1.42 derived: net income ÷ weighted average shares · filed 2023-02-14 | $2.59 derived: net income ÷ weighted average shares · filed 2023-02-14 | $3.27 derived: net income ÷ weighted average shares · filed 2023-02-14 | $4.07 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.16 10-Q · filed 2021-10-26 | $1.84 derived: net income ÷ weighted average shares · filed 2021-10-26 | $2.64 10-Q · filed 2021-10-26 | $3.47 derived: net income ÷ weighted average shares · filed 2022-02-15 |
| 2020-06-30 | $0.68 10-Q · filed 2021-07-27 | $1.48 10-Q · filed 2021-07-27 | $2.31 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.97 derived: net income ÷ weighted average shares · filed 2022-02-15 |
| 2020-03-31 | $0.80 10-Q · filed 2021-04-27 | $1.63 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.29 derived: net income ÷ weighted average shares · filed 2022-02-15 | $3.06 derived: net income ÷ weighted average shares · filed 2022-02-15 |
| 2019-12-31 | $0.82 10-K · filed 2020-02-25 | $1.49 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.25 derived: net income ÷ weighted average shares · filed 2022-02-15 | $2.79 10-K · filed 2022-02-15 |
| 2019-09-30 | $0.67 10-Q · filed 2020-10-27 | $1.43 derived: net income ÷ weighted average shares · filed 2020-10-27 | $1.97 10-Q · filed 2020-10-27 | $2.60 derived: net income ÷ weighted average shares · filed 2021-02-16 |
| 2019-06-30 | $0.76 10-Q · filed 2020-07-28 | $1.30 10-Q · filed 2020-07-28 | $1.94 derived: net income ÷ weighted average shares · filed 2021-02-16 | $2.48 derived: net income ÷ weighted average shares · filed 2021-02-16 |
| 2019-03-31 | $0.54 10-Q · filed 2020-04-29 | $1.17 derived: net income ÷ weighted average shares · filed 2021-02-16 | $1.71 derived: net income ÷ weighted average shares · filed 2021-02-16 | $2.18 derived: net income ÷ weighted average shares · filed 2021-02-16 |
| 2018-12-31 | $0.64 10-K · filed 2020-02-25 | $1.18 derived: net income ÷ weighted average shares · filed 2021-02-16 | $1.64 derived: net income ÷ weighted average shares · filed 2021-02-16 | $2.05 10-K · filed 2021-02-16 |
| 2018-09-30 | $0.54 10-K · filed 2020-02-25 | $1.01 derived: net income ÷ weighted average shares · filed 2019-10-29 | $1.41 10-Q · filed 2019-10-29 | $1.71 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-06-30 | $0.46 10-K · filed 2020-02-25 | $0.87 10-Q · filed 2019-07-30 | $1.18 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.42 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-03-31 | $0.41 10-K · filed 2020-02-25 | $0.71 derived: net income ÷ weighted average shares · filed 2020-02-25 | $0.96 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.19 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2017-12-31 | $0.30 10-K · filed 2019-02-26 | $0.56 derived: net income ÷ weighted average shares · filed 2020-02-25 | $0.79 derived: net income ÷ weighted average shares · filed 2020-02-25 | $1.00 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.25 10-K · filed 2019-02-26 | $0.49 derived: net income ÷ weighted average shares · filed 2018-10-30 | $0.70 10-Q · filed 2018-10-30 | $0.69 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2017-06-30 | $0.24 10-K · filed 2019-02-26 | $0.44 10-Q · filed 2018-07-31 | $0.44 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.58 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2017-03-31 | $0.21 10-K · filed 2019-02-26 | $0.21 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.34 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.49 derived: net income ÷ weighted average shares · filed 2019-02-26 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 | $0.13 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.27 derived: net income ÷ weighted average shares · filed 2019-02-26 | $0.38 10-K · filed 2019-02-26 |
| 2016-09-30 | $0.14 10-K · filed 2018-02-27 | $0.29 derived: net income ÷ weighted average shares · filed 2017-10-31 | $0.39 10-Q · filed 2017-10-31 | |
| 2016-06-30 | $0.15 10-K · filed 2018-02-27 | $0.26 10-Q · filed 2017-08-01 | ||
| 2016-03-31 | $0.11 10-K · filed 2018-02-27 | |||
| 2015-12-31 | -$0.27 10-K · filed 2017-02-28 | -$0.28 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $0.00 10-K · filed 2017-02-28 | $0.00 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $0.00 10-K · filed 2017-02-28 | |||
| 2015-03-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2014-12-31 | -$0.46 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |